Nearly all investigations on CSF NFL in ALS agree that the levels of the biomarker do not differ between male and female patients (Gaiani et al., 2017; Skillbäck et al., 2017; Rossi et al., 2018). Here, NEFL is linked to amyotrophic lateral sclerosis.